Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mitoxantrone hydrochloride lymphatic tracer injection for sentinel lymph node mapping in breast cancer
CTR20192435Phase 3Completed
- Sponsor
- Shenyang Pharmaceutical University
- Start
- Jan 2020
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mitoxantrone in breast cancer, sponsored by Shenyang Pharmaceutical University. Started Jan 2020; status: completed.
02
Drugs
mitoxantrone
03
Conditions
breast cancer
Beyond the preview
Go deeper on CTR20192435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192435.